Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase NA 2Phase 2 2Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 62Leukemia, Myeloid, Acute 51Myelodysplastic Syndromes 39Leukemia 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Leukemia, Myelomonocytic, Chronic 34Leukemia, Lymphocytic, Chronic, B-Cell 26Blast Crisis 23Myeloproliferative Disorders 20Congenital Abnormalities 20Multiple Myeloma 17Anemia, Refractory 15Myelodysplastic-Myeloproliferative Diseases 14Hodgkin Disease 14Anemia 14Primary Myelofibrosis 13Lymphoma 13Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 13Lymphoma, Non-Hodgkin 12Leukemia, Myeloid, Chronic-Phase 12Thrombocytopenia 11Neoplasms, Plasma Cell 11Lymphoma, Mantle-Cell 11Leukemia, Myeloid, Accelerated Phase 11Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Large B-Cell, Diffuse 10Hematologic Neoplasms 10Burkitt Lymphoma 10Lymphoma, Follicular 9Leukemia, Prolymphocytic 8

Interventions

Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Fever × Classical hematology × Clear all
NCT02948283 2021-02-12

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 1 Completed
3 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Lymphadenopathy, Anemia, Fatigue, Fever, Lymphocytosis, Multiple Myeloma, Splenomegaly, Thrombocytopenia, Weight Loss, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡